Review and results of a survey about biosimilars prescription and challenges in the Middle East and North Africa region.

Springerplus · 2016 · PMC5201599 · PMID 28090427

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

Although this reduction may not be significant but seems to be sufficient to generate high profitable rates (Lockwood et al. 2013 ).

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.